FDA Approves CHILDRENS IBUPROFEN — Advagen Pharma Ltd.

# FDA Approves Advagen Pharma's Generic Children's Ibuprofen Advagen Pharma Ltd. received FDA approval for its generic Children's Ibuprofen oral formulation (ANDA220239) on March 5, 2026, adding another player to the competitive pediatric pain relief market and potentially increasing pricing pressure on existing brand-name and generic competitors. The approval could expand treatment accessibility for parents seeking cost-effective fever and pain management options for children.